Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

CMOP±R

Phase 2Small molecule

TThe First Affiliated Hospital of Soochow University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

NHLRecruiting

NHLPhase 2

Recruiting

Timeline

Expected Milestones

Q3 2027

Phase 2Recruiting

NHL

NCT06486337

Clinical

Trials by Indication[1]

NHL1 trial

A Single-arm, Multi-center, Prospective Clinical Study of Mitoxantrone Hydrochloride Liposome Injection-based CMOP±R Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma

Recruiting·TThe First Affiliated Hospital of Soochow University·Phase 2·NCT06486337·197 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for CMOP±R. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — CMOP±R compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for CMOP±R. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The First Affiliated Hospital of Soochow University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: TThe First Affiliated Hospital of Soochow University

Related News